SCHEMBL7803301

SCHEMBL7803301

CCCCCCCCCCOC(=O)NCCCC[C@H](N)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ACHE P22303 13/20 0.62
EPHX2 P34913 2/20 0.55
NOD1 Q9Y239 3/20 0.53
GNAI3 P08754 1/20 0.52
GNAO1 P09471 1/20 0.52
GNAI1 P63096 1/20 0.52
DPP7 Q9UHL4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7804987 1.00 ACHE (0.62) ACHEEPHX2NOD1GNAI3GNAO1
SCHEMBL7797292 1.00 ACHE (0.62) ACHEEPHX2NOD1GNAI3GNAO1
SCHEMBL7804961 1.00 ACHE (0.62) ACHEEPHX2NOD1GNAI3GNAO1
SCHEMBL9061677 0.96 ACHE (0.64) ACHEEPHX2NOD1
SCHEMBL16053917 0.95 ACHE (0.56) ACHEEPHX2NOD1GNAI3GNAO1
SCHEMBL457464 0.94 ACHE (0.57) ACHEEPHX2GNAI3GNAO1GNAI1
SCHEMBL7534573 0.94 ACHE (0.57) ACHEEPHX2GNAI3GNAO1GNAI1
SCHEMBL16054345 0.92 ACHE (0.56) ACHEEPHX2NOD1GNAI3GNAO1
SCHEMBL20663448 0.87 ACHE (0.49) ACHEEPHX2NOD1GNAI3GNAO1
SCHEMBL7797290 0.86 GNAI3 (0.50) ACHENOD1GNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010055620-A1 New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions L'OREAL 2001-12-27 US claimed
EP-0652209-B1 Derivatives of N-epsilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions OREAL (FR) 1998-04-08 EP claimed
EP-0652209-A1 Derivatives of N-episilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions L'OREAL (FR) 1995-05-10 EP claimed
US-20010055620-A1 New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions L'OREAL 2001-12-27 US disclosed
US-6207173-B1 Lysine derivatives containing an Nε-alkoxy or Nε-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions L'OREAL (FR) 2001-03-27 US disclosed
EP-0652209-B1 Derivatives of N-epsilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions OREAL (FR) 1998-04-08 EP disclosed
EP-0652209-A1 Derivatives of N-episilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions L'OREAL (FR) 1995-05-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010055620-A1 New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions DOT1L, KDM7A, JMJD6 ACHE 1589/4885EPHX2 335/4885NOD1 2327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.